SEC Tracker
Get the app

Rallybio RLYB

Rallybio postpones merger closing

Merger communication

Form
425
Filed
Importance
Routine
  1. Merger with Avenzo Therapeutics delayed
  2. Closing conditions not fully satisfied
  3. Cash distribution funds not deposited
  4. Payment and ex-dividend dates may be delayed

Written from the 425 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Rallybio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Brainstorm Cell Therapeutics BCLI public float $10M, Jun 30, 2025
  2. Kiora Pharmaceuticals KPRX public float $10M, Jun 30, 2025
  3. Scienture Holdings SCNX public float $10M, Jun 30, 2025
  4. Phio Pharmaceuticals PHIO public float $11M, Jun 30, 2025
  5. Palisade Bio PALI public float $11M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.